
George Ng
CEO and Board Director @ Processa Pharmaceuticals
About
George Ng, a partner at PENG Life Science Ventures (PENG LSV), is a seasoned life sciences industry executive. He has founded and/or led multiple companies, including Scilex Pharmaceuticals, Inc., where he was Co-Founder and President, and led the company through development, clinical trials, NDA submission, FDA approval, $140 million financing, commercial launch of the company’s first FDA-approved drug product, and company sale/merger. Mr. Ng has also held various other senior management positions, including Board Director, Managing Director, Chief Business Officer, Chief Administrative Officer, Corporate Secretary, Chief Legal Officer, General Counsel, Chief Compliance Officer and Chief Intellectual Property Counsel, with publicly-traded and private, global biotechnology and pharmaceutical companies, including Sorrento Therapeutics, Inc. (NASDAQ: SRNE), BioDelivery Sciences International, Inc. (NASDAQ: BDSI), Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) and Alpharma, Inc. (now, a part of Pfizer Inc.). In these roles, Mr. Ng helped lead the development and commercialization efforts and launches of multiple pharmaceutical drug products. Previously, in private practice, Mr. Ng was a partner in two AMLAW 200 law firms, where he had leadership roles, including establishing the life sciences practice group for one firm and heading it as the national co-chair. Additionally, Mr. Ng is a current member of the Board of Directors or Advisor for multiple companies, including Iacta Pharmaceuticals, Inc., Inflammatory Response Research, Inc. (IRR), Morphogenesis, Inc. and Calidi Biotherapeutics, Inc.
United States
San Diego
Biotechnology
Business Development, Business Strategy, Intellectual Property, Biotechnology, Medical Devices, Life Sciences, Science, Patent preparation, Patents, Licensing, Investigations, Due Diligence, Prosecution, Patent Prosecution, Pharmaceuticals, Trade Secrets, Mergers, Compliance, Licensing Agreements, Contract Negotiation
Experience

Partner
PENG Life Science Ventures
San Diego, California

Member, Board Of Directors
Invent Medical Corporation
Carlsbad, California

Board Director
Seoul, South Korea
George Ng negotiated and was the US-company lead in forming the first South Korean joint venture between a major South Korean pharmaceutical company, Yuhan Corporation (KRX: 000100) and US pharmaceutical company, Sorrento Therapeutics (NASDAQ: SRNE). Subsequently, Mr. Ng helped manage and lead the JV into clinical studies, as a member of the Board of Directors.

Executive Vice President & Chief Administrative Officer
San Diego, California
George Ng was Executive Vice President, Chief Administrative Officer & Chief Legal Officer for Sorrento Therapeutics, Inc., where he heads the administrative, legal, human resources, compliance, IT and intellectual property functions. In addition, Mr. Ng acted as the company’s Corporate Secretary and oversaw and led the business matters of various subsidiaries and joint ventures of the company, including: Scilex Pharmaceuticals, Inc. (President, Business), Virttu Biologics Limited (Managing Director) and ImmuneOncia Therapeutics Inc. (Board Director).
George Ng's Contact Information
Phone
Find the Right Leads
Find Verified Contact Data
What LeadContact does well
Find verified emails, phone numbers, and decision-makers with 98% accuracy.
Find Leads
Find the right people by company, role, industry, location, and more.
925M+ professional profiles

Find Emails
Access verified email addresses for your target contacts.
657M+ emails

Find Phone Numbers
Get cross-validated phone data from multiple top sources.
239M+ phone numbers

More Accurate. Lower Cost.
Find contact data in 1 tool with 98% accuracy
LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.
Great conversations start with the right contact.
It’s time to find yours.








